| Place of Origin: | Shanghai in China |
|---|
Quick Details
- Purity: 99%
- Brand Name: Bocimed
- Grade Standard: Medicine Grade
- CAS No.: 357336-20-0
Specifications
We provide Brivaracetam API
CAS 357336-20-0
Purity is no less than 99%
Shanghai Bocimed Pharmaceutical Co., Ltd. (Bocimed) was established in Shanghai Zhangjiang Pharma Valley in 2012. Bocimed has more than 100 product development technologies, focusing on various therapeutic areas including oncology, cardiovascular science, immunology, neurological and mental health. Bocimed is focus on R&D and manufacture of API and intermediates, and provides products for lab and commercial quantity.
Brivaracetam is an orally bioavailable derivative, with anticonvulsant activity. Although the exact mechanism through which brivaracetam exerts its effects is not fully known, this agent targets and binds to synaptic vesicle protein 2A (SV2A) in the brain. this prevents synaptic vesicle exocytosis and the synaptic release of certain, as of yet not fully known, excitatory neurotransmitters. this may inhibit impulse conduction across synapses, decrease neuronal (hyper-)excitability, and may modulate epileptogenesis. SV2A, a membrane glycoprotein present in neuronal synaptic vesicles, plays a key role in action potential-induced neurotransmitter release in the brain.
